These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8972490)

  • 1. The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes.
    Acosta JA; Benzaquen LR; Goldstein DJ; Tosteson MT; Halperin JA
    Mol Med; 1996 Nov; 2(6):755-65. PubMed ID: 8972490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells.
    Halperin JA; Taratuska A; Nicholson-Weller A
    J Clin Invest; 1993 May; 91(5):1974-8. PubMed ID: 8486768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.
    Kilgore KS; Flory CM; Miller BF; Evans VM; Warren JS
    Am J Pathol; 1996 Sep; 149(3):953-61. PubMed ID: 8780399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane permeability to macromolecules mediated by the membrane attack complex.
    Malinski JA; Nelsestuen GL
    Biochemistry; 1989 Jan; 28(1):61-70. PubMed ID: 2706268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells.
    Benzaquen LR; Nicholson-Weller A; Halperin JA
    J Exp Med; 1994 Mar; 179(3):985-92. PubMed ID: 8113689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism?
    Mignatti P; Rifkin DB
    J Cell Biochem; 1991 Nov; 47(3):201-7. PubMed ID: 1724242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation.
    Kilgore KS; Schmid E; Shanley TP; Flory CM; Maheswari V; Tramontini NL; Cohen H; Ward PA; Friedl HP; Warren JS
    Am J Pathol; 1997 Jun; 150(6):2019-31. PubMed ID: 9176395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane vesiculation protects erythrocytes from destruction by complement.
    Iida K; Whitlow MB; Nussenzweig V
    J Immunol; 1991 Oct; 147(8):2638-42. PubMed ID: 1918984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1.
    Kilgore KS; Shen JP; Miller BF; Ward PA; Warren JS
    J Immunol; 1995 Aug; 155(3):1434-41. PubMed ID: 7543521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex.
    Mignatti P; Morimoto T; Rifkin DB
    J Cell Physiol; 1992 Apr; 151(1):81-93. PubMed ID: 1560052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microassay for the pore-forming activity of complement, perforin, and other cytolytic proteins based on confocal laser scanning microscopy.
    Sauer H; Pratsch L; Peters R
    Anal Biochem; 1991 May; 194(2):418-24. PubMed ID: 1862943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
    Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
    Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro.
    Kaye D; Pimental D; Prasad S; Mäki T; Berger HJ; McNeil PL; Smith TW; Kelly RA
    J Clin Invest; 1996 Jan; 97(2):281-91. PubMed ID: 8567946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth.
    Cozzolino F; Torcia M; Lucibello M; Morbidelli L; Ziche M; Platt J; Fabiani S; Brett J; Stern D
    J Clin Invest; 1993 Jun; 91(6):2504-12. PubMed ID: 7685771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine growth regulation of human glomerular mesangial cells is primarily mediated by basic fibroblast growth factor.
    Francki A; Uciechowski P; Floege J; von der Ohe J; Resch K; Radeke HH
    Am J Pathol; 1995 Nov; 147(5):1372-82. PubMed ID: 7485400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural biology of the membrane attack complex.
    Sonnen AF; Henneke P
    Subcell Biochem; 2014; 80():83-116. PubMed ID: 24798009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha.
    Saadi S; Holzknecht RA; Patte CP; Platt JL
    Circulation; 2000 Apr; 101(15):1867-73. PubMed ID: 10769290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis.
    Pilzer D; Fishelson Z
    Int Immunol; 2005 Sep; 17(9):1239-48. PubMed ID: 16091382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
    Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
    J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emission of membrane vesicles: roles in complement resistance, immunity and cancer.
    Pilzer D; Gasser O; Moskovich O; Schifferli JA; Fishelson Z
    Springer Semin Immunopathol; 2005 Nov; 27(3):375-87. PubMed ID: 16189651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.